Class I - Dangerous
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
💊
Prescription Drugs
💊 Drugs • 11,927 recalls
Class I - Dangerous
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.
Class I - Dangerous
Subpotent
Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton, NJ 08540, Distributed by Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product of Canada, NDC 54643-5649-1
Mckesson Medical-Surgical Inc. Corporate Office
Class I - Dangerous
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Class I - Dangerous
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Preferred Pharmaceuticals
Class I - Dangerous
cGMP Deviations
Class I - Dangerous
Subpotent
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
Mckesson Medical-Surgical Inc. Corporate Office
Class I - Dangerous
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Class I - Dangerous
Subpotent
Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11
Denver Solutions, LLC
Class I - Dangerous
Lack of Assurance of Sterility: Leaking/damaged syringes.
Class I - Dangerous
cGMP deviations
Class I - Dangerous
cGMP deviations
Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10
Breckenridge Pharmaceutical
Class I - Dangerous
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Class I - Dangerous
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class I - Dangerous
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Class I - Dangerous
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class I - Dangerous
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Class I - Dangerous
Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
Class I - Dangerous
Lack of Assurance of Sterility: Leaking/damaged syringes.